America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A fresh review finds that a $10,000 investment in rsp’s equal-weight trap: $10,000 lagged a cap-weighted S&P 500 fund...
Microsoft trades at a decade-low multiple as AI tools expand and Copilot adoption lags. Investors weigh the AI upside...
As market conditions shift in 2026, VFIAX remains a top pick for buy-and-hold strategies. The fund combines a low 0.0...
The NEOS QQQI ETF paid out $7.63 per share in the last 12 months, yet the fund trailed the Nasdaq-100 rally as invest...
Nvidia delivered a record quarterly revenue of $68.1 billion and projected $78 billion for the coming quarter, driven...
Hims & Hers is set to report Q1 earnings after the close as investors weigh a rebound in shares and the pace of cash ...
A new breed of daily-reset covered-call ETFs aims to preserve more upside while delivering monthly income. Here’s how...
Mortgage rates have shifted from stubborn highs to a window of lower financing costs. This article shows how investor...
Investors often wrestle with where to place bets: a volatile crypto project or a disruptive nuclear-tech equity. This...
U.S.-Israel strikes on Iran trigger sharp market moves as Trump calls regime change, raising the stakes for investors...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...